Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10442139Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$1.5M
Full award amounts, FY2025
Award Records
1
Records listing this PI
Award-Linked Rank
#10,059
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2025): $1.5M in linked award amounts across 1 award record · Award-linked rank #10059.
FY2025 award records by amount
NIH award records listing Edmund Nesti as a PI. Multi-PI records show the full award amount for context.
- 1R44NS145934-01R44FDA Phase 1 Development of a Novel Nonopioid Cell and Tissue Permeable Peptide Therapeutic for Epigenetic Reprogramming of Neuropathic Pain$1.5Maward amount
Award organization
Organizations that administered FY2025 awards listing Edmund Nesti as a PI.
FY2025 award administered by Alcamena Stem Cell Therapeutics, Llc (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardAlcamena Stem Cell Therapeutics, Llc
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding